THA Clinical Trials in Chicago, Illinois
14 recruitingChicago, Illinois
Showing 1–14 of 14 trials
Recruiting
Phase 3
A Study to Evaluate Long-term Safety in Participants Who Have Participated in Other Luspatercept (ACE-536) Clinical Trials
Beta-ThalassemiaMyelodysplastic Syndromes (MDS)Myeloproliferative Neoplasm(MPN)-Associated Myelofibrosis
Celgene665 enrolled143 locationsNCT04064060
Recruiting
Not Applicable
Self-Adhering Magnetic Device to Treat Corneal Exposure
Paralytic LagophthalmosCorneal Exposure
University of Illinois at Chicago25 enrolled1 locationNCT06291818
Recruiting
Phase 2
Targeting the Pathophysiology of Sickle Cell-Related Kidney Disease Using the SGLT2 Inhibitors, Empagliflozin
AlbuminuriaSickle Cell Anemia (HbSS, or HbSβ-thalassemia0)
University of Illinois at Chicago20 enrolled1 locationNCT07175051
Recruiting
Phase 2
A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma
GerminomaBasal Ganglia GerminomaDiabetes Insipidus+3 more
Children's Oncology Group240 enrolled109 locationsNCT06368817
Recruiting
Phase 3
Parasitic Ulcer Treatment Trial
Acanthamoeba keratitis
Jeremy Keenan, MD, MPH232 enrolled17 locationsNCT06213649
Recruiting
An Observational Study of Individuals With Isolated Dystonia
Isolated/Primary Dystonia That Affects More Than One Region of the Body
Vima Therapeutics200 enrolled29 locationsNCT07111663
Recruiting
Phase 3
A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia
Sickle Cell DiseaseThalassemia
Novo Nordisk A/S480 enrolled103 locationsNCT06609226
Recruiting
Phase 3
A Trial of Setmelanotide in Patients With Congenital Hypothalamic Obesity (Sub-study of NCT05774756)
Hypothalamic ObesityMultiple Pituitary Hormone Deficiency Genetic FormSepto-Optic Dysplasia+3 more
Rhythm Pharmaceuticals, Inc.39 enrolled11 locationsNCT06760546
Recruiting
ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
ThrombophiliaThrombosisSickle Cell Disease+10 more
American Thrombosis and Hemostasis Network3,000 enrolled71 locationsNCT04398628
Recruiting
Phase 1Phase 2
A Study of RM-718 in Healthy Subjects and Patients With MC4R Pathway Impairment
Prader-Willi SyndromeHypothalamic ObesityPWS
Rhythm Pharmaceuticals, Inc.150 enrolled7 locationsNCT06239116
Recruiting
Phase 2
Brain-Computer Interface Visualization Training to Optimize Muscle Activation Following Orthopaedic Surgery
Hip arthroscopyTotal Hip Arthroplasty (THA)Total Knee Arthroplasty+1 more
Rush University Medical Center240 enrolled1 locationNCT07020312
Recruiting
International Rapid-onset Obesity with Hypothalamic Dysfunction, Hypoventilation & Autonomic Dysregulation (ROHHAD) Registry
ROHHADRapid-Onset Obesity with Hypothalamic Dysfunction, Hypoventilation & Autonomic Dysregulation
Debra Weese-Mayer1,000 enrolled1 locationNCT03135730
Recruiting
Phase 2
Study of Olutasidenib and Temozolomide in HGG
Metastatic Brain TumorIDH1 MutationAstrocytoma, Grade IV+16 more
Rigel Pharmaceuticals60 enrolled18 locationsNCT06161974
Recruiting
Not Applicable
An mHealth Strategy to Improve Medication Adherence in Adolescents With Sickle Cell Disease
Sickle Cell DiseaseSickle Beta Zero ThalassemiaSickle B+ Thalassemia+1 more
Ann & Robert H Lurie Children's Hospital of Chicago40 enrolled1 locationNCT04688411